Mr. Jim Breslin:

I will make a point on the policy position, although I will not go into the issue of the dispensing of the drug.

The supervising injecting rooms are policy and the pilot is well advanced. There are 90 drug consumption rooms operating around the world. We have looked at them. Undoubtedly, there is a reduction in blood-borne transmission of diseases in them. It also presents an opportunity to get a public health message across to people, including those who have hepatitis C, about how they could deal with it. It is one of the core rationales for using supervised injection facilities.